cro概念股延续涨势,截至发稿,凯莱英(06821)涨12.06%,报108.7港元;康龙化成(03759)涨6.66%,报20.65港元;昭衍新药(06127)涨6.56%,报22.75港元;药明生物(02269)涨3.65%,报29.8港元。消息面上,国家药监局药品注册管理司司长杨霆表示,在研发管线方面,中国目前创新药的研发管线占到了全球的大约1/4,在临床试验上我们每年有大概3000个项目...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.